Among the three signature genes, ADAM12 was overexpressed in SCLC and might serve as a potential prognostic biomarker of SCLC (Duan et al., 2019; Shao et al., 2014; Xiong et al., 2018). Here, ADAM12 is linked to small cell lung carcinoma.